The nef protein of human immunodeficiency virus establishes superinfection immunity by a dual strategy to downregulate cell-surface CCR5 and CD4

Current Biology

Volumn 15, Issue 8, 2005, Pages 714-723

  Michel, Nico ^a   Allespach, Ina ^a   Venzke, Stephanie ^a   Fackler, Oliver T ^a   Keppler, Oliver T ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 18044378256     PISSN: 09609822     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cub.2005.02.058     Document Type: Article

References (45)

1. S. Bour, R. Geleziunas, and M.A. Wainberg The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection Microbiol. Rev. 59 1995 63 93
2. J. Schneider-Schaulies, J.J. Schnorr, U. Brinckmann, L.M. Dunster, K. Baczko, U.G. Liebert, S. Schneider-Schaulies, and V. ter Meulen Receptor usage and differential downregulation of CD46 by measles virus wild-type and vaccine strains Proc. Natl. Acad. Sci. USA 92 1995 3943 3947
3. M. Marschall, H. Meier-Ewert, G. Herrler, G. Zimmer, and H.F. Maassab The cell receptor level is reduced during persistent infection with influenza C virus Arch. Virol. 142 1997 1155 1164
4. K.M. Breiner, S. Urban, B. Glass, and H. Schaller Envelope protein-mediated down-regulation of hepatitis B virus receptor in infected hepatocytes J. Virol. 75 2001 143 150
5. J. Lama The physiological relevance of CD4 receptor down-modulation during HIV infection Curr. HIV Res. 1 2003 167 184
6. C.D. Pauza, J.E. Galindo, and D.D. Richman Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells J. Exp. Med. 172 1990 1035 1042
7. H.L. Robinson, and D.M. Zinkus Accumulation of human immunodeficiency virus type 1 DNA in T cells: Results of multiple infection events J. Virol. 64 1990 4836 4841
8. W.A. Paxton, and S. Kang Chemokine receptor allelic polymorphisms: Relationships to HIV resistance and disease progression Semin. Immunol. 10 1998 187 194
9. D.L. Tuttle, J.K. Harrison, C. Anders, J.W. Sleasman, and M.M. Goodenow Expression of CCR5 increases during monocyte differentiation and directly mediates macrophage susceptibility to infection by human immunodeficiency virus type 1 J. Virol. 72 1998 4962 4969
10. L. Wu, W.A. Paxton, N. Kassam, N. Ruffing, J.B. Rottman, N. Sullivan, H. Choe, J. Sodroski, W. Newman, and R.A. Koup CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1, in vitro J. Exp. Med. 185 1997 1681 1691
11. M. Geyer, O.T. Fackler, and B.M. Peterlin Structure-function relationships in HIV-1 Nef EMBO Rep. 2 2001 580 585
12. W.C. Greene, and B.M. Peterlin Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy Nat. Med. 8 2002 673 680
13. R.W. Doms, and D. Trono The plasma membrane as a combat zone in the HIV battlefield Genes Dev. 14 2000 2677 2688
14. O.T. Fackler, and A.S. Baur Live and let die: Nef functions beyond HIV replication Immunity 16 2002 493 497
15. R.E. Benson, A. Sanfridson, J.S. Ottinger, C. Doyle, and B.R. Cullen Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection J. Exp. Med. 177 1993 1561 1566
16. S.J. Little, N.L. Riggs, M.Y. Chowers, N.J. Fitch, D.D. Richman, C.A. Spina, and J.C. Guatelli Cell surface CD4 downregulation and resistance to superinfection induced by a defective provirus of HIV-1 Virology 205 1994 578 582
17. X. Lu, H. Yu, S.H. Liu, F.M. Brodsky, and B.M. Peterlin Interactions between HIV1 Nef and vacuolar ATPase facilitate the internalization of CD4 Immunity 8 1998 647 656
18. A. Verani, and P. Lusso Chemokines as natural HIV antagonists Curr. Mol. Med. 2 2002 691 702
19. X. Xiao, L. Wu, T.S. Stantchev, Y.R. Feng, S. Ugolini, H. Chen, Z. Shen, J.L. Riley, C.C. Broder, and Q.J. Sattentau Constitutive cell surface association between CD4 and CCR5 Proc. Natl. Acad. Sci. USA 96 1999 7496 7501
20. F. Cocchi, A.L. DeVico, A. Garzino-Demo, S.K. Arya, R.C. Gallo, and P. Lusso Identification of RANTES, MIP-1 alpha, and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells Science 270 1995 1811 1815
21. N. Signoret, A. Pelchen-Matthews, M. Mack, A.E. Proudfoot, and M. Marsh Endocytosis and recycling of the HIV coreceptor CCR5 J. Cell Biol. 151 2000 1281 1294
22. C. Aiken, J. Konner, N.R. Landau, M.E. Lenburg, and D. Trono Nef induces CD4 endocytosis: Requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain Cell 76 1994 853 864
23. O. Schwartz, V. Marechal, S. Le Gall, F. Lemonnier, and J.M. Heard Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein Nat. Med. 2 1996 338 342
24. T. Mirzabekov, N. Bannert, M. Farzan, W. Hofmann, P. Kolchinsky, L. Wu, R. Wyatt, and J. Sodroski Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor J. Biol. Chem. 274 1999 28745 28750
25. V. Piguet, L. Wan, C. Borel, A. Mangasarian, N. Demaurex, G. Thomas, and D. Trono HIV-1 Nef protein binds to the cellular protein PACS-1 to downregulate class I major histocompatibility complexes Nat. Cell Biol. 2 2000 163 167
26. A.D. Blagoveshchenskaya, L. Thomas, S.F. Feliciangeli, C.H. Hung, and G. Thomas HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway Cell 111 2002 853 866
27. A.L. Chenine, Q. Sattentau, and M. Moulard Selective HIV-1-induced downmodulation of CD4 and coreceptors Arch. Virol. 145 2000 455 471
28. J. Lama, A. Mangasarian, and D. Trono Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef- and Vpu-inhibitable manner Curr. Biol. 9 1999 622 631
29. T.M. Ross, A.E. Oran, and B.R. Cullen Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein Curr. Biol. 9 1999 613 621
30. M.R. Kasper, and K.L. Collins Nef-mediated disruption of HLA-A2 transport to the cell surface in T cells J. Virol. 77 2003 3041 3049
31. S. Carl, A.J. Iafrate, S.M. Lang, C. Stahl-Hennig, E.M. Kuhn, D. Fuchs, K. Matz-Rensing, P. ten Haaft, J.L. Heeney, and J. Skowronski The acidic region and conserved putative protein kinase C phosphorylation site in Nef are important for SIV replication in rhesus macaques Virology 257 1999 138 155
32. S. Carl, T.C. Greenough, M. Krumbiegel, M. Greenberg, J. Skowronski, J.L. Sullivan, and F. Kirchhoff Modulation of different human immunodeficiency virus type 1 Nef functions during progression to AIDS J. Virol. 75 2001 3657 3665
33. Z. Hanna, X. Weng, D.G. Kay, J. Poudrier, C. Lowell, and P. Jolicoeur The pathogenicity of human immunodeficiency virus (HIV) type 1 Nef in CD4C/HIV transgenic mice is abolished by mutation of its SH3-binding domain, and disease development is delayed in the absence of Hck J. Virol. 75 2001 9378 9392
34. N. Casartelli, G. Di Matteo, M. Potesta, P. Rossi, and M. Doria CD4 and major histocompatibility complex class I downregulation by the human immunodeficiency virus type 1 nef protein in pediatric AIDS progression J. Virol. 77 2003 11536 11545
35. K.L. Collins, B.K. Chen, S.A. Kalams, B.D. Walker, and D. Baltimore HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes Nature 391 1998 397 401
36. C. Butticaz, A. Ciuffi, M. Munoz, J. Thomas, A. Bridge, S. Pebernard, R. Iggo, P. Meylan, and A. Telenti Protection from HIV-1 infection of primary CD4 T cells by CCR5 silencing is effective for the full spectrum of CCR5 expression Antivir. Ther. 8 2003 373 377
37. N. Zhou, J. Fang, M. Mukhtar, E. Acheampong, and R.J. Pomerantz Inhibition of HIV-1 fusion with small interfering RNAs targeting the chemokine coreceptor CXCR4 Gene Ther. 11 2004 1703 1712
38. M. Castedo, K.F. Ferri, J. Blanco, T. Roumier, N. Larochette, J. Barretina, A. Amendola, R. Nardacci, D. Metivier, and J.A. Este Human immunodeficiency virus 1 envelope glycoprotein complex-induced apoptosis involves mammalian target of rapamycin/FKBP12-rapamycin-associated protein-mediated p53 phosphorylation J. Exp. Med. 194 2001 1097 1110
39. G.H. Holm, C. Zhang, P.R. Gorry, K. Peden, D. Schols, E. De Clercq, and D. Gabuzda Apoptosis of bystander T cells induced by human immunodeficiency virus type 1 with increased envelope/receptor affinity and coreceptor binding site exposure J. Virol. 78 2004 4541 4551
40. C.B. Davis, I. Dikic, D. Unutmaz, C.M. Hill, J. Arthos, M.A. Siani, D.A. Thompson, J. Schlessinger, and D.R. Littman Signal transduction due to HIV-1 envelope interactions with chemokine receptors CXCR4 or CCR5 J. Exp. Med. 186 1997 1793 1798
41. D. Weissman, R.L. Rabin, J. Arthos, A. Rubbert, M. Dybul, R. Swofford, S. Venkatesan, J.M. Farber, and A.S. Fauci Macrophage-tropic HIV and SIV envelope proteins induce a signal through the CCR5 chemokine receptor Nature 389 1997 981 985
42. M. Tremblay, S. Meloche, S. Gratton, M.A. Wainberg, and R.P. Sekaly Association of p56lck with the cytoplasmic domain of CD4 modulates HIV-1 expression EMBO J. 13 1994 774 783
43. M. Zaitseva, K. Peden, and H. Golding HIV coreceptors: Role of structure, posttranslational modifications, and internalization in viral-cell fusion and as targets for entry inhibitors Biochim. Biophys. Acta 1614 2003 51 61
44. A. Jung, R. Maier, J.P. Vartanian, G. Bocharov, V. Jung, U. Fischer, E. Meese, S. Wain-Hobson, and A. Meyerhans Multiply infected spleen cells in HIV patients Nature 418 2002 144
45. K. Levesque, A. Finzi, J. Binette, and E.A. Cohen Role of CD4 receptor down-regulation during HIV-1 infection Curr. HIV Res. 2 2004 51 59